This inventor holds 1 USPTO granted patent. Top assignee: The Radiochemical Centre Limited. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: The Innovations of Maurice Alexander Stewart
Introduction
Maurice Alexander Stewart is a notable inventor based in Amersham, GB. He has made significant contributions to the field of medical imaging, particularly through his innovative work in body scanning agents. His expertise and dedication to advancing technology in healthcare have earned him recognition in the scientific community.
Latest Patents
Stewart holds a patent for a body scanning agent, specifically a Technetium-99m labelled tin colloid for liver scanning. This invention involves the addition of Technetium-99m, in the form of an aqueous solution of pertechnetate ion TcO.sub.4.sup.-, to a reagent that includes one part by weight of sodium, potassium, or ammonium fluoride and from 0.00075 to 0.75 parts by weight of stannous tin. This innovative approach enhances the effectiveness of liver scans, providing clearer and more accurate imaging results.
Career Highlights
Stewart is associated with The Radiochemical Centre Limited, where he has been instrumental in developing advanced radiopharmaceuticals. His work has contributed to improving diagnostic techniques in medicine, particularly in the field of nuclear medicine. With a patent portfolio that includes 1 patent, he continues to push the boundaries of what is possible in medical imaging.
Collaborations
Stewart has collaborated with various professionals in his field, including his coworker, John Barry Laidler. Their combined expertise has fostered innovation and development in radiochemical applications.
Conclusion
Maurice Alexander Stewart's contributions to the field of medical imaging through his patented innovations demonstrate his commitment to enhancing healthcare technology. His work continues to impact the medical community positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile